Solara Active Pharma Sciences Limited (NSE:SOLARA)
India
· Delayed Price · Currency is INR 530.50
+12.00 (2.31%)
Apr 24, 2025, 3:29 PM IST
NSE:SOLARA Revenue
Solara Active Pharma Sciences had revenue of 3.00B INR in the quarter ending December 31, 2024, with 20.74% growth. This brings the company's revenue in the last twelve months to 13.10B, down -6.87% year-over-year. In the fiscal year ending March 31, 2024, Solara Active Pharma Sciences had annual revenue of 12.89B, down -10.73%.
Revenue (ttm)
13.10B
Revenue Growth
-6.87%
P/S Ratio
1.96
Revenue / Employee
6.08M
Employees
2,156
Market Cap
25.67B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Solara Active Pharma Sciences News
- 2 months ago - Solara Active Pharma shares down 5% as Managing Director Poorvank Purohit resigns - Business Upturn
- 3 months ago - Solara Active Pharma Sciences announces demerger of CRAMS and Polymers business - Business Upturn
- 3 months ago - Solara Active Pharma Sciences Q3 FY25 Results: Revenue up 41.6% YoY to Rs 300.31 crore - Business Upturn
- 6 months ago - Solara Active Pharma Sciences Ltd (BOM:541540) Q2 2025 Earnings Call Highlights: Record Gross ... - GuruFocus